Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRHR | P34981 | 6/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11815435 | 0.97 | TRHR (0.57) | TRHR | |
| SCHEMBL11820778 | 0.97 | TRHR (0.57) | TRHR | |
| Protirelin SCHEMBL11669085 | 0.92 | TRHR (0.68) | TRHR | |
| Protirelin SCHEMBL8364920 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL14280929 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL20659679 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL11798811 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL2182035 | 0.92 | TRHR (0.71) | TRHR | |
| SCHEMBL1369554 | 0.91 | TRHR (0.63) | TRHR | |
| SCHEMBL27209499 | 0.91 | TRHR (0.56) | TRHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5225529-A | Central nervous system disorders such as Alzheimer*s disease | FARMHISPANIA S.A. (ES) | 1993-07-06 | — | — | US | claimed |
| EP-0381070-A1 | Synthetic amphiphilic glycoconjugates for neurological use | FARMHISPANIA S.A. (ES) | 1990-08-08 | — | — | EP | claimed |
| WO-2026089754-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026089752-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| CN-114516898-A | Preparation method and application of thyrotropin releasing hormone | 上海丽珠制药有限公司 | 2022-05-20 | — | — | CN | disclosed |
| US-5225529-A | Central nervous system disorders such as Alzheimer*s disease | FARMHISPANIA S.A. (ES) | 1993-07-06 | — | — | US | disclosed |
| EP-0381070-A1 | Synthetic amphiphilic glycoconjugates for neurological use | FARMHISPANIA S.A. (ES) | 1990-08-08 | — | — | EP | disclosed |
| US-4297346-A | PSYCHOACTIVE DRUGS BONDED TO NEUROPEPTIDES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 1981-10-27 | — | — | US | disclosed |
| US-4066635-A | ANTIDEPRESSANTS | HOFFMANN-LA ROCHE INC. (US) | 1978-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | MUC1, VIP, LGALS4 | TRHR 280/4885 |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FGF23, FIBP, PTMS | TRHR 1002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.